TROG Cancer Research
Members Login   CQMS Login  

Other events and meetings

 

Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research, 18-21 October 2017

The joint congress, to be held at Brisbane Convention and Exhibition Centre, will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research. This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.

Abstract submission deadline: 7 May 2017

E: congress@worldmelanoma2017.com
W: www.worldmelanoma2017.com


Previous Meetings

ANZHNCS ASM and the International Federation of Head and Neck Oncologic Societies (IFHNOS) 2016 World Tour, 25-27 October 2016

The Australian and New Zealand Head & Neck Cancer Society (ANZHNCS) ASM and the IFHNOS 2016 World Tour will be held from 25-27 October 2016 at The Langham Auckland, New Zealand. This meeting is designed for health professionals working in the area of head and neck oncology including; ENT surgeons, plastic and reconstructive surgeons, head and neck surgeons, oral and maxillofacial surgeons, medical oncologists, surgical oncologists including endocrine surgeons, radiation oncologists, registrars, speech pathologists, nurses, dietitians, psychologists, medical students and other health professionals.

Provisional topics include oral cancer, thyroid cancer, multidisciplinary therapy, salivary tumours, operative techniques in head and neck surgery, minimally invasive surgery, larynx preservation, stump the faculty, reconstructive surgery, oropharyngeal tumours, melanoma and skull base surgery. For further information:

E: anzhncs.asm@surgeons.org   
T: +61 3 9249 1260
W: www.ifhnosauckland2016.org


2016 SABR Symposium, 18-19 November 2016

Proudly hosted by the Peter MacCallum Cancer Centre, this multi-disciplinary teaching program is applicable to Radiation Oncologists, Radiation Therapists, Radiation Oncology Medical Physicists, and Radiation Therapy Nurses. Held at Peter MacCallum Cancer Centre’s new home, the 2016 SABR Symposium is designed as a comprehensive educational tool for practitioners at all levels of experience, conveyed through both lecture sessions and interactive workshops. Full registration is limited to 120 participants. 

Invited international speaker - Robert Timmerman, M.D.
Professor of Radiation Oncology and Neurosurgery, and Effie Marie Cain Distinguished Chair in Cancer Therapy Research at the University of Texas Southwestern Medical Center in Dallas, Texas

Register now at www.sabr2016.co

Winner – 'Innovation in Cancer Clinical Trials' Award, 2013 NSW Premier’s Awards for Outstanding Cancer Research


Latest News

  • 11 Oct 2017

    figure>_ alt="file 20171009 25784 3p8oeb.png?ixlib=rb 1.1" src="https://images.theconversation.com/files/189307/original/file-20171009-25784-3p8oeb.png?ixlib=rb-1.1.0&q=45&auto=format&w=754" /> figcaption>randomisation is the only commonly accepted method of ensuring an unbiased esti...

  • 11 Oct 2017

    more than 65 people showed their support for cancer research by attending a high tea fundraising event hosted by trog cancer research. the event was held in newcastle, where the trog cancer research has its headquarters. on top of a delicious high tea, guests also took part in a silen...

  • 06 Oct 2017

    the trillions of bacteria living in our gut (called the gut microbiota) can help determine our risk of cancer, as well as how we might respond to cancer treatment. each person’s unique gut microbiota is in constant . this ensures good bacteria can thrive in the _, while bad bacteria a...

  • 12 Sep 2017

    trog cancer research is pleased to announce the appointment of john cleary to its board. ceo joan torony said that john was a perfect fit for trog’s board as he has more than 20 years’ experience at a senior management and executive level in both the not-for-profit and for-profit indu...

  • 17 Jul 2017

    p style="text-align: center;">_ src="/sitefiles/trogcomau/julie_with_mask.jpg" style="height: 338px; width: 600px;" /> trog cancer research is excited to announce julie mccrossin, well-known and respected broadcaster, journalist and former tv host, as its new ambassador. julie has ...

  • 17 Jul 2017

    alex carmichael has always been a busy man. during his career he was an executive working for many major australian companies. he's also served as a director of public companies and on the board of many government organisations. he's always been interested in building a better society...

  • 04 Jul 2017

    margaret and narelle first met when they were in year four at primary school. the pair have stayed friends since this time and now they are embarking on a trip of a life-time - trekking the wilds of tasmania, raising vital funds for cancer research. margaret and narelle have decide...

  • 16 Jun 2017

    patients with advanced skin cancer can now be spared from having to undergo chemotherapy, with results from a new australian study showing that surgery combined with radiotherapy is a more effective treatment. professor sandro porceddu who headed the trog cancer research ‘post’ tri...

  • 13 Jun 2017

    westmead hospital is now home to a world-first prostate cancer trial, using revolutionary technology to dramatically slash treatment times. the hospital is the first site in western sydney to run the spark clinical trial. trog's spark trial is underway in several nsw hospitals. it ...

  • 30 May 2017

    in a brain cancer breakthrough, an international clinical trial , has found that adding temozolomide chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma (gbm), ...

  • 30 May 2017

    in a world-first breakthrough for early stage low-grade lymphoma, set to change the management of the disease worldwide, an international clinical trial has found that patients live longer when immuno-chemotherapy is combined with radiotherapy. the results of the international phas...